NCI Precision Medicine Study Hones in on Cancer Remission
Researchers say a non-chemotherapy treatment is causing more cancer patients to experience full remission.
A recent National Cancer Institute study shows that a new targeted therapy can help prolong the time cancer patients are in remission. Called the ViPOR regimen, the non-chemotherapy treatment shrinks tumors of those who suffer from B-cell lymphoma.
Dr. Christopher Melani, associate research physician with the Lymphoid Malignancies Branch in the Center for Cancer Research at NCI, highlights the importance of combining five therapies and administering them during a fixed cycle to maximize drug synergy and make tumors disappear.
He also shares details about the second phase of the study that is expected to take place later this year as well as how precision medicine could potentially lead to a cure for all types of cancer.
-
Dr. Christopher Melani Associate Research Physician, Lymphoid Malignancies Branch, Center for Cancer Research NCI
-
TEFCA Hits Half-Billion Record Exchange Milestone
HHS Deputy Secretary Jim O’Neill highlights exponential growth as ASTP plans to advance interoperability regulation.
3m read -
New NPS Challenge Aims to Rewrite How the Military Builds Missiles
Officials say focusing on design methods, not hardware, could unlock fast, low‑cost manufacturing for future munitions.
11m watch -
CMS to Invest in Tech Talent to Strengthen Efficiency, Modernization
Amy Gleason said CMS needs stronger in-house tech talent and access to modern tools to improve efficiency and drive modernization.
3m read -
The Value of ‘Pause, Breathe, Summarize’ in Cyber Leadership
A simple framework for clarity when everything feels urgent.
25m listen
